NYMC Faculty Publications
Role for Risk Factor Treatment in the Management of Atrial Fibrillation
DOI
10.1080/21548331.2020.1784663
Journal Title
Hospital Practice
First Page
180
Last Page
187
Document Type
Article
Publication Date
10-2020
Department
Medicine
Keywords
Atrial Fibrillation, Cardiovascular Diseases, Chronic Disease, Diabetes Mellitus, Disease Management, Healthy Lifestyle, Humans, Obesity, Patient Care Team, Primary Prevention, Quality of Life, Risk Factors, Sleep Apnea Syndromes
Disciplines
Cardiology | Medicine and Health Sciences
Abstract
Atrial fibrillation is the most common arrhythmia in the world with continued rising prevalence, significant morbidity and mortality, and a substantial financial burden. It has been associated with numerous modifiable risk factors and chronic medical conditions. Treatment of these modifiable risk factors has improved rhythm control of atrial fibrillation as well as demonstrated cost-effectiveness. Primary prevention of underlying chronic disease should be incorporated into the treatment paradigm for AF. Comprehensive management with integrated care including the patient, allied health professionals, primary care physicians, and specialists will be needed to reverse the epidemiological trends, improve quality of life, and mortality.
Recommended Citation
Frenkel, D., & Aronow, W. S. (2020). Role for Risk Factor Treatment in the Management of Atrial Fibrillation. Hospital Practice, 48 (4), 180-187. https://doi.org/10.1080/21548331.2020.1784663
